One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
Genetic testing in cardiomyopathies and new therapeutic target in cardiac remodelling
doi : 10.1093/eurheartj/ehae890
Volume 46, Issue 4, 21 January 2025
A Manifesto from Global Heart Hub for early detection and diagnosis of cardiovascular disease
Target 130/80: a future-focused initiative for hypertension management in Azerbaijan
Integration of genetic testing into diagnostic pathways for cardiomyopathies: a clinical consensus statement by the ESC Council on Cardiovascular Genomics
Targeting fibroblast phenotype switching in cardiac remodelling as a promising antifibrotic strategy
Hypertrophic cardiomyopathy evolving management: American Heart Association/American College of Cardiology vs. European Society of Cardiology guidelines
Clinical features and outcomes in carriers of pathogenic desmoplakin variants
Desmoplakin cardiomyopathy: a step towards understanding the genetic basis of phenotypic and outcome heterogeneity
Enhanced Parkin-mediated mitophagy mitigates adverse left ventricular remodelling after myocardial infarction: role of PR-364
Weekly Journal Scan: RESHAPing potential treatment indications for functional mitral regurgitation in heart failure
